Axiom Therapeutics
Entrepreneur First '24London, GB · Founded 2024 · 4 known investors
Axiom Therapeutics runs a drug discovery platform for covalent inhibitors, applying machine learning to speed up physics-based simulations. The work is aimed at oncology research teams pursuing targets that have been difficult to drug.
Biotech
Founders & leadership
Axiom Therapeutics was founded in 2024 by Ryan Geiser and Chris Haggard.
RG
Ryan GeiserinCEORyan Geiser completed a PhD in Biophysical Chemistry at the University of Cambridge as a Gates Scholar, with research that yielded new drug candidates. He later worked at Lazard, where he advised on billion-dollar biopharma transactions.
CH
Chris HaggardinCTOChris Haggard earned a PhD in Computational Chemistry from the University of Cambridge, focusing on quantum simulation and machine learning approaches for modelling molecules. That research underpins the technology behind Axiom Therapeutics.
Investors · 4
Frequently asked questions
- What does Axiom Therapeutics do?
- Axiom Therapeutics runs a drug discovery platform for covalent inhibitors, applying machine learning to speed up physics-based simulations. The work is aimed at oncology research teams pursuing targets that have been difficult to drug.
- Who founded Axiom Therapeutics?
- Axiom Therapeutics was founded by Ryan Geiser, Chris Haggard in 2024.
- Who are Axiom Therapeutics's investors?
- Axiom Therapeutics's investors include Entrepreneur First, Lunar Ventures, Samos Investments, Transpose Platform Management.
- Where is Axiom Therapeutics headquartered?
- Axiom Therapeutics is headquartered in London, GB.